Journal
NEURO-ONCOLOGY
Volume 21, Issue 8, Pages 981-992Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/neuonc/noz028
Keywords
atypical neurofibromas; benign-to-malignant transformation; malignant peripheral nerve sheath tumor; neurofibromatosis type 1; plexiform neurofibromas
Categories
Funding
- Intramural Research Program of the Division of Cancer Epidemiology and Genetics
- Center for Cancer Research of the National Cancer Institute, Bethesda, Maryland
- National Human Genome Research Institute, Bethesda, Maryland
- Department of Defense DAMD [DAMD 179810689]
- Children's Tumor Foundation Neurofibroma Therapeutics Acceleration Award
- NIH [NS31550]
- NATIONAL CANCER INSTITUTE [ZIABC011427] Funding Source: NIH RePORTER
- NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200346, ZIAHG200330, ZIBHG000196] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Background. Neurofibromatosis type 1 (NF1) is a tumor-predisposition disorder caused by germline mutations in NF1. NF1 patients have an 8-16% lifetime risk of developing a malignant peripheral nerve sheath tumor (MPNST), a highly aggressive soft-tissue sarcoma, often arising from preexisting benign plexiform neurofibromas (PNs) and atypical neurofibromas (ANFs). ANFs are distinct from both PN and MPNST, representing an intermediate step in malignant transformation. Methods. In the first comprehensive genomic analysis of ANF originating from multiple patients, we performed tumor/normal whole-exome sequencing (WES) of 16 ANFs. In addition, we conducted WES of 3 MPNSTs, copy-number meta-analysis of 26 ANFs and 28 MPNSTs, and whole transcriptome sequencing analysis of 5 ANFs and 5 MPNSTs. Results. We identified a low number of mutations (median 1, range 0-5) in the exomes of ANFs (only NF1 somatic mutations were recurrent), and frequent deletions of CDKN2A/B (69%) and SMARCA2 (42%). We determined that polycomb repressor complex 2 (PRC2) genes EED and SUZ12 were frequently mutated, deleted, or downregulated in MPNSTs but not in ANFs. Our pilot gene expression study revealed upregulated NRAS, MDM2, CCND1/2/3, and CDK4/6 in ANFs and MPNSTs, and overexpression of EZH2 in MPNSTs only. Conclusions. The PN-ANF transition is primarily driven by the deletion of CDKN2A/B. Further progression from ANF to MPNST likely involves broad chromosomal rearrangements and frequent inactivation of the PRC2 genes, loss of the DNA repair genes, and copy-number increase of signal transduction and cell-cycle and pluripotency self-renewal genes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available